Azasan 100 MG tablet 100S
Ended Awarded
- Contract number
- SPE2DB25FZL24
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,011
Award facts
- Contract value 100% obligated
- $1,010.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,010.61 to DMS Pharmaceutical Group Inc. for the supply of Azasan 100 mg tablets (100 count) on September 22, 2025, with completion scheduled for September 23, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed in Park Ridge, Illinois, where the awardee is headquartered. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected to fulfill this requirement under its larger Indefinite Delivery Contract with the DLA's SPE2DB program, valued at $499,999,999 and extending through November 2026.
This delivery order represents a routine pharmaceutical supply requirement supporting the medical needs of Department of Defense healthcare facilities. DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain, with a comprehensive portfolio covering prescription medications, biologics, and medical consumables, positions the company to efficiently deliver specialty pharmaceutical products like Azasan (azathioprine), an immunosuppressive agent used in various medical applications. The company's consistent performance record with the DLA and its status as a woman-owned small business have enabled it to compete effectively and maintain a significant position in federal pharmaceutical procurement markets.
Quick answers
Who was awarded contract SPE2DB25FZL24?
SPE2DB25FZL24 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FZL24 worth?
The government has obligated $1,011 on SPE2DB25FZL24.
Is contract SPE2DB25FZL24 an order under another contract?
Yes. SPE2DB25FZL24 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZL24 competed?
The extent of competition for SPE2DB25FZL24 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award